Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-701115
Filing Date
2016-09-06
Accepted
2016-09-02 21:38:02
Documents
5
Period of Report
2016-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d193159d6k.htm 6-K 10490
2 EX-99.1 d193159dex991.htm EX-99.1 198178
3 GRAPHIC g193159g63a93.jpg GRAPHIC 2186
4 GRAPHIC g193159g95w27.jpg GRAPHIC 9431
5 GRAPHIC g193159g97w85.jpg GRAPHIC 2191
  Complete submission text file 0001193125-16-701115.txt   229052
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 161869694
SIC: 2834 Pharmaceutical Preparations